PharmiWeb.com - Global Pharma News & Resources
04-Feb-2021

Helicobacter Pylori Diagnostics Market in Forthcoming Years Defining Industry Size, Growth Rate of 7.1% In 2020 with Rising Global Opportunities by Segmentation, Trends and Regional Outlook 2026

Global Helicobacter Pylori Diagnostics Market

Helicobacter is a spiral-shaped gram-negative bacteria, causing chronic inflammation and infection in the stomach and duodenum, leading to acute ulceration. H. pylori is found in around 50-80% of patients with gastric ulcers, and in 90% of patients with duodenal ulcers. Infected individuals experience long-term asymptomatic conditions, with nearly 70% of individuals having minimal symptoms, such as belching, bloating, nausea, vomiting, and abdominal discomfort. The major symptoms include abdominal pain, peptic ulcer, bad breath, etc. Helicobacter infection can be diagnosed using gastric mucosa samples, which are obtained through endoscopy and are used for biopsy or non-invasive tests that require blood or stool samples. Invasive tests include immunoassay, rapid urease test, and histology, whereas, the non-invasive tests include stool antigen assays serology tests, and urea tests.

Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-sample/1874

The global Helicobacter pylori diagnostics market was pegged at US$ 437.3 million in 2017 and is foreseen to witness a CAGR of 7.1% over the forecast period (2018-2026).

Increasing prevalence of H. pylori in emerging economies is propelling the global market growth

Th prevalence rate of helicobacter pylori has been declining in developed countries, while, on the other hand, it has been ascending in the emerging economies across the world. According to the Faculty of Medicine of The Chinese University of Hong Kong (CUHK), in 2017, around 4.4 billion people worldwide are infected with Helicobacter pylori (H. pylori). Furthermore, the same source suggested that prevalence in Africa is up to 80%, which is the highest globally, while in Asia, over 50% of the population was infected with H. pylori. Moreover, according to the International Agency for Research on Cancer report 2014, in 2012, around 952,000 new gastric cancer cases occurred globally and around 734,000 gastric cancers were estimated to occur due to H. pylori infection. Such high prevalence of Helicobacter pylori in Africa and Asia is expected to fuel the helicobacter pylori diagnostics market growth in these regions.

However, the limitations associated with these diagnostic tests are expected to constrain the growth of the global Helicobacter pylori diagnostics market. For instance, serology-based assays have low sensitivity and specificity, as they are unable to differentiate between active infection and IgG antibodies present post treatment.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1874

Global Helicobacter Pylori Diagnostics Market – Regional Segmentation

The North America Helicobacter pylori diagnostic market holds the leading position in the global market, and this market growth is attributed to the increasing initiatives being taken to provide test kits at low costs in order to eradicate the H. pylori infection. For instance, antibody-based detection tests are available at lower cost for enhancing the eradication of helicobacter pylori infection in Quebec. Moreover, Agence d’évaluation des technologies et des modes d’intervention en santé (AETMIS), an independent body reporting to the Quebec Minister of Health and Social Services, recommends the 13C-urea breath test to be made available in all areas of Québec. However, Africa Helicobacter pylori diagnostic market is expected to exhibit high CAGR, owing to high prevalence of Helicobacter pylori. According to the studies published in the Gastroenterology Journal, the data suggested that Africa has recorded the highest prevalence rate (around 79%) of H. pylori infection in the recent past.

Inorganic strategies adopted by key market players to favor the global market expansion

The key players involved in the global Helicobacter pylori diagnostics market include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories Inc., Diasorin S.P.A., Quidel Corporation, F. Hoffmann-La Roche Ltd.(Ventana Medical Systems, Inc.), Meridian Bioscience, Inc., Exalenz Bioscience Ltd., Abbott Laboratories, Cardinal Health, Inc., and Halyard Health, Inc.

These manufacturers have been concentrating on adopting various inorganic strategies, in order to enhance their product offerings. For instance, Diasorin S.P.A., in September 2017, acquired ELISA technology business from Siemens, with an aim of shifting the current client base that uses ELISA tests towards CLIA technology solutions. As a part of agreement, Siemens will continue to manufacture and supply ELISA immunodiagnostic kits exclusively for DiaSorin for the next three years.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/global-helicobacter-pylori-diagnostics-market-to-surpass-us-8074-million-by-2026-981

Detailed Segmentation:

  • Global Helicobacter Pylori Diagnostics Market, By Test Type:
    • Invasive
      • Immunoassay
      • Rapid Urease Test
      • Histology
    • Non-invasive
      • Stool Antigen Assays
      • Serology Tests
      • Urea Breath Test
    • Global Helicobacter Pylori Diagnostics Market, By End User:
      • Hospitals
      • Clinics
      • Diagnostic Laboratories
      • Others
  • Global Helicobacter Pylori Diagnostics Market, By Region:
    • North America Helicobacter Pylori Diagnostics Market
      • By Test Type:
        • Invasive
          • Immunoassay
          • Rapid Urease Test
          • Histology
        • Non-invasive
          • Stool Antigen Assays
          • Serology Tests
          • Urea Breath Test
        • By End User:
          • Hospitals
          • Clinics
          • Diagnostic Laboratories
          • Others
        • By Country:
          • U.S.
          • Canada
    • Latin America Helicobacter Pylori Diagnostics Market
      • By Test Type:
        • By End User:
        • By Country:
          • Brazil
          • Mexico
          • Argentina
          • Rest of Latin America
    • Europe Helicobacter Pylori Diagnostics Market
      • By Test Type:
        • By End User:
        • By Country:
          • Germany
          • U.K.
          • Italy
          • France
          • Spain
          • Russia
          • Rest of Europe
    • Asia Pacific Helicobacter Pylori Diagnostics Market
      • By Test Type:
        • By End User:
        • By Country:
          • China
          • India
          • Japan
          • ASEAN
          • Australia
          • South Korea
          • Rest of Asia Pacific
    • Middle East Helicobacter Pylori Diagnostics Market
      • By Test Type:
        • By End User:
        • By Country:
          • GCC
          • Israel
          • Rest of Middle East
    • Africa Helicobacter Pylori Diagnostics Market
      • By Test Type:
        • By End User:
        • By country:
          • North Africa
          • Central Africa
          • South Africa
About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 04-Feb-2021